Advanced search
Publication Cover
Future Oncology Volume 20, 2024 - Issue 3
Submit an article Journal homepage
1,065
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

In-Class Transition from Bortezomib-Based Therapy to IRd is an Effective Approach in Newly Diagnosed Multiple Myeloma

Robert M Rifkin1 Rocky Mountain Cancer Centers/US Oncology Research, Denver, CO��80218, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3141-1518View further author information
ORCID Icon,
Caitlin L Costello2 Department of Medicine, Division of Blood & Marrow Transplantation, Moores Cancer Center, University of California San Diego, La Jolla, CA��92037, USAView further author information
,
Ruemu E Birhiray3 Hematology Oncology of Indiana/American Oncology Network, Indianapolis, IN��46260, USAView further author information
,
Suman Kambhampati4 Kansas City Veterans Affairs Medical Center, Kansas City, MO��64128, USAView further author information
,
Joshua Richter5 Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY��10029, USAORCID Iconhttps://orcid.org/0000-0002-0274-0585View further author information
ORCID Icon,
Rafat Abonour6 Indiana University School of Medicine, Indianapolis, IN��46202, USAView further author information
,
Hans C Lee7 M.D. Anderson Cancer Center, Houston, TX��77030, USAView further author information
,
Michael Stokes8 Evidera, Data Analytics, St-Laurent, Quebec, H4T 1V6, CanadaView further author information
,
Kaili Ren9 Takeda Development Center Americas, Inc. (TDCA), Lexington, MA��02412, USAView further author information
,
Dawn Marie Stull10 Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA��02421, USAView further author information
,
Dasha Cherepanov9 Takeda Development Center Americas, Inc. (TDCA), Lexington, MA��02412, USAView further author information
,
Kimberly Bogard10 Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA��02421, USAView further author information
,
Stephen J Noga10 Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA��02421, USAView further author information
&
Saulius Girnius11 TriHealth Cancer Institute, Cincinnati, OH��45247, USAView further author information
 show all
Pages 131-143 | Received 31 Mar 2023, Accepted 07 Sep 2023, Published online: 09 Oct 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.